Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Pfizer: COVID-19 Vaccine Shows High Efficacy

November 09, 2020

Interim efficacy data suggests the Pfizer/BioNTech has an efficacy rate above 90%.

Improving Solubility with Amorphous Solid Dispersions

November 03, 2020

Amorphous solid dispersions are a useful tool in overcoming solubility issues, but they have not yet reached full potential in commercial success.

Understanding the Impact of Annex 1 on Isolator Design

November 03, 2020

An optimal engineering design is crucial for aseptic operation and cleaning.

RCPE Awarded FDA Funding to Develop Next-Generation Technology

October 29, 2020

Two FDA-funded projects at RCPE will look at real-time monitoring and control of drug tablet coating and developing a digital twin for drug production control.

Novavax COVID-19 Vaccine Trial Expands Enrollment

October 27, 2020

The Phase III clinical trial of NVX-CoV2373 is expected to be fully enrolled in the UK and will begin in the US and Mexico by the end of November 2020.

Novavax Begins Phase III Efficacy Trial of COVID-19 Vaccine

September 25, 2020

A clinical trial to enroll up to 10,000 volunteers across the UK will assess whether NVX-CoV2373 is effective in the prevention of COVID-19.

UK Prime Minister Visits Team Behind the Vaccines Manufacturing and Innovation Centre

September 24, 2020

UK's Prime Minister visited the site of the country’s VMIC in Oxfordshire, and met the teams working at the forefront of the national COVID-19 response.

Johnson & Johnson Launches Multi-Country Phase III Trial of Janssen’s COVID-19 Vaccine Candidate

September 23, 2020

A Phase III trial to evaluate safety and efficacy of Janssen’s COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S, is enrolling participants on three continents.

Russia Completes Deals with India, Mexico, and Brazil for Sputnik V

September 17, 2020

The Russian Direct Investment Fund has announced three deals with India, Brazil, and Mexico, for the supply of doses of Sputnik V, a potential COVID-19 vaccine.

Considering Materials for Vaccine Containers

September 16, 2020

Polymeric containers offer an alternative to glass.